Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?

Author
Bakir, Baris
Iyibozkurt, Cem
Adalet, Isik
Mudun, Ayse
Topuz, Samet
Turkmen, Cuneyt
Sanli, Yasemin
Unal, Seher
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/100589
Collections